Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.5 USD | -2.63% | -4.41% | +20.73% |
04-30 | Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals | MT |
04-30 | Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.73% | 3.87B | |
+22.05% | 46.4B | |
-1.68% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.95% | 26.01B | |
-19.66% | 19.52B | |
+29.90% | 12.43B | |
-0.16% | 12.18B | |
-0.65% | 12.13B |
- Stock Market
- Equities
- ALVO Stock
- News Alvotech
- Alvotech Shares Rise After Signing Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in US